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Topic 36 – Biomarkers
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Chronic pressure overload (PO) induces pathological left ventricular hyper-
trophy (LVH) leading to congestive heart failure (HF). Over-expression of
FKBP12.6 (FK506 binding protein (K)) in mice should prevent Ca2+-leak
during diastole and may improve overall cardiac function. In order to decipher
molecular mechanisms involved in thoracic aortic constriction (TAC)-induced
cardiac remodelling and the influence of gender and genotype, we performed
a proteomic analysis using 2D-DIGE, mass spectrometry and bioinformatics
techniques to identify alterations in characteristic biological networks.
Wild type (W) and K mice of both genders underwent TAC. Thirty days
post-TAC, the altered cardiac remodelling was accompanied with systolic
and diastolic dysfunction in all experimental groups. A gender difference in
inflammatory protein expression (fibrinogen, alpha-1-antitrypsin isoforms)
and in calreticulin occurred (males > females). Detoxification enzymes and
cytoskeletal proteins were noticeably increased in K mice. Both non- and
congestive failing mouse heart exhibited down- and up-regulation of pro-
teins related to mitochondrial function and purine metabolism, respectively.
HF was characterized by a decrease in enzymes related to iron homeostasis,
and altered mitochondrial protein expression related to fatty acid metabo-
lism, glycolysis and redox balance. Moreover, two distinct differential pro-
tein profiles characterized TAC-induced pathological LVH and congestive
HF in all TAC mice. FKBP12.6 over-expression did not influence TAC-
induced deleterious effects. Huntingtin was revealed as a potential mediator
for HF. A broad dysregulation of signaling proteins associated with conges-
tive HF suggested that different sets of proteins could be selected as useful
biomarkers for HF progression and might predict outcome in PO-induced
pathological LVH.
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Introduction: ACS diagnosis relies on the detection of an increase or a
decrease in troponin levels (delta-TnI) that might be estimated as absolute
(delta-TnI-abs) or relative value (delta-TnI-rel). The discriminative cut-off
value of delta-TnI to identify ACS in patients admitted in ICU is a matter of
debate. 
Methods: We aimed to determine in a monocentric registry the cut-off
value of delta-TnI to identify ACS among patients admitted in ICU with a sus-
picion of acute myocardial ischemia.  All the patients had 2 measurements of
ultrasensible cTnI (ADVIA Centaur Siemens®; 99th percentile: 0,04 μg/L).
Patients were classified in 4 groups: 1) ACS (NSTEMI, UA), 2) Cardiac non
coronary diseases (heart failure, PE, arrhythmia, pericarditis, myocarditis, syn-
cope, Tako-Tsubo), 3) Non cardiac diseases (pneumonia, stroke, epilepsy,
neoplasm), 4) Chest pain of unknown origin (musculo-skelettal pain…)
Results: 275 patients were included. Medians of delta-TnI-abs were 0.12
[0 ; 1.01] ; 0.01 [0 ; 0.03] ; 0 [-0.01 ; 0] et 0  [0 ; 0] μg/L in groups 1 to 4
respectively. Medians of delta-TnI-rel) were 104 [0 ; 680] ; 2 [0 ; 62] ; 0 [-6 ;
0] et 0 [0 ; 0] % in groups 1 to 4 respectively. The delta-TnI-abs was signifi-
cantly different between groups 1 and 2 (p=0.026). ROC curve analysis
showed that optimal threshold of delta-TnI-abs was 0.02 μg/L (sensitivity
67%, specificity 76%) to distinguish group 1 from groups 2, 3 and 4. The
threshold was 0.04 μg/L (sensitivity 61%, specificity 80%) to distinguish
group 1 from group 2. The use of delta-TnI-rel yielded similar results and the
only confounder was age.
Conclusion: This study suggests that the cut-off of delta-TnI to identify
ACS in ICU patients should be higher to be discriminative of cardiac non cor-
onary diseases. The identification of type 1 and type 2 myocardial infarction
is a major challenge and needs further research.
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Background: Elevated N-terminal Pro B-type Natriuretic Peptide (NT
Pro-BNP) levels are correlated with the severity of left ventricular systolic
dysfunction and left ventricular filling alterations. Besides, left atrial (LA) size
is believed to reflect chronic diastolic dysfunction. 
Aim: Evaluate the relationship between NT Pro-BNP and LA size.
Methods: 81 patients (77.7% males; mean age, 61.55±15 years), with left
ventricular systolic dysfunction (left ventricular ejection fraction [LVEF]
<55%), underwent transthoracic echocardiography to evaluate LA size and
venous blood sampling to determine NT-pro-BNP levels. 
Results: Mean LVEF was 35.6±10.8 % (LVEF <35% in 32 patients). The
NT Pro-BNP values were elevated (mean 3304±4218.9 pg/ml). Higher NT
Pro-BNP was significantly correlated to LA size (r=0.56, p<0.001). The
optimal cut-off value to predict LA size >20 cm2 was 1188 pg/mL (area under
the receiver-operating characteristic curve [AUC] 0.83 [0.71–0.93], p<0.0001,
sensitivity 77.6%, specificity 75%).
Conclusion: The present study shows that plasma NT Pro-BNP levels is
strongly correlated to LA size. NT-proBNP level more than 1188 pg/mL may
suggest LA dilatation.
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Background: Growth differentiation factor-15 (GDF-15) has been identi-
fied as a strong marker for cardiovascular disease; however, no data are avail-
able concerning the role of GDF-15 in the occurrence of organ dysfunction
during cardiac surgery associated with cardiopulmonary bypass (CPB).
Methods: Thirty four patients, programmed to have non-urgent coronary
artery bypass grafting (CABG), were included in our study. Arterial blood
samples were taken sequentially from anesthesia induction (IND) until 24h
after arrival at the cardiovascular intensive care unit (ICU). Plasma levels of
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GDF-15, follistatin-like 1 (FLST1), myeloperoxidases (MPO), hydroperoxides
and plasma antioxidant status (PAS) were measured at each time-point.
Markers of cardiac (cardiac-troponin I, cTnI) and renal dysfunction (neutro-
phil gelatinase-associated lipocalin, NGAL) and other classical biological fac-
tors and clinical data were measured.
Results: GDF-15 plasma levels increased gradually during surgery and
after, reaching nearly than three time IND levels in the ICU (2,904±282 ng/L
vs. 1,061±90 ng/L, p<0.001). MPO plasma levels increased dramatically just
after unclamping (UNCLAMP, 49±11ng/mL vs. 1,116±94ng/mL, p<0.001)
while PAS significantly decreased between IND and UNCLAMP (p<0.05),
confirming the high oxidative status of this surgical procedure. Compared with
IND levels, cTnI and NGAL increased significantly (p<0.001) after surgery.
ICU levels of GDF-15 and NGAL were positively associated (p=0.026).
Conclusions: During cardiac surgery associated with CPB, GDF-15 levels
were notably increased and associated with markers of cardiac injury, renal
dysfunction (urea, creatinin, GFR, NGAL) and glycaemia.
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